Forge Health, a top provider of outpatient mental health and substance use care, has secured a strategic growth investment from MFO Ventures. This funding will support the optimization and expansion…
ADVI Health is excited to announce the acquisition of Partnership for Health Analytic Research (PHAR), a leading global consultancy specializing in health technology assessment (HTA) and health economics and outcomes…
Invenra Inc. is excited to announce that its innovative bispecific antibody, INV724, designed for the treatment of neuroblastoma, has received both Rare Pediatric Disease (RPDD) and Orphan Drug (ODD) Designations…
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a nonprofit healthcare provider serving over one million people in Virginia and West Virginia, have…
Actio Biosciences, a biotechnology firm focused on utilizing a novel genetic and precision medicine platform to create therapeutics for both rare and common diseases, has appointed Dr. Dimitrios Arkilo as…
DermBiont, a clinical-stage biotech company specializing in innovative topical treatments for rare oncology and dermatology conditions, has reported promising initial results from its open-label, multi-center Phase 2a trial for basal…
Success Beyond Game Day and SHREDmill have partnered to integrate AI-driven mindset training into XPE’s SHREDmill platform and online community. This collaboration seeks to elevate the overall development of athletes…
Universal DX (UDX) has completed its Series B funding round, which will support the clinical trial for its colorectal cancer screening blood test, Signal-C®. This trial is a key step…
Astria Therapeutics, Inc. (NASDAQ: ATXS), a biopharmaceutical company dedicated to advancing treatments for allergic and immunological diseases, has announced its partnership with Ypsomed for developing an autoinjector for STAR-0215. This…
Zura Bio Limited (Nasdaq: ZURA), a clinical-stage immunology company specializing in dual-pathway antibodies for autoimmune and inflammatory diseases, has completed its exchange offer and consent solicitation for its outstanding IPO…
Nucleus Biologics, The Cell Performance Company™, a top provider of custom cell culture media and buffers for the cell and gene therapy sector, is excited to introduce its new QuickStart…
According to a new quarterly revenue cycle benchmarking report from Kodiak Solutions, health insurers are increasingly using requests for additional information to initially deny claims from hospitals, health systems, and…